Article Details
Retrieved on: 2021-03-31 11:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The European Commission has granted marketing authorisation to Roche's Evrysdi™ (risdiplam) as a treatment for spinal muscular atrophy in infants, ...
Article found on: www.europeanpharmaceuticalreview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here